Literature DB >> 20843616

Comparison of the Sensititre YeastOne® dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains.

S Bertout1, C Dunyach, P Drakulovski, J Reynes, M Mallié.   

Abstract

The Clinical Laboratory Standards Institute ([CLSI] formerly NCCLS) reference broth microdilution testing method (protocol M27-A3) was compared with a commercially available methods (Sensititre YeastOne(®)) by testing two quality control strains and 102 isolates of Candida sp. and Cryptococcus sp. against fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole, flucytosin, amphotericin B and caspofungin. Minimal inhibitory concentrations (MIC) endpoints were determined after 24h of incubation for Sensititre YeastOne(®) and after 24 and 48 h for CLSI microdilution method. Essential agreements between methods vary from 70.6 to 92.2%. Categorical agreements vary from 94.1% for 5FC to 72.6% for AMB. Sensititre YeastOne(®) reading appears to be useful for avoiding very major errors and this confirms the interest of this method for evaluating new antifungals activity in vitro.
Copyright © 2010. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843616     DOI: 10.1016/j.patbio.2010.07.020

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  9 in total

1.  A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.

Authors:  Somanon Bhattacharya; Jack D Sobel; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.

Authors:  Hedda Luise Koehling; Birgit Willinger; Jan Buer; Peter-Michael Rath; Joerg Steinmann
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

3.  Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.

Authors:  Hsuan-Chen Wang; Ming-I Hsieh; Pui-Ching Choi; Chi-Jung Wu
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America.

Authors:  Lisa M Singer; Wieland Meyer; Carolina Firacative; George R Thompson; Eileen Samitz; Jane E Sykes
Journal:  J Clin Microbiol       Date:  2014-04-02       Impact factor: 5.948

5.  Comparison of aglycon and glycosidic saponin extracts of Cyclamen coum tuber against Candida spp.

Authors:  S T Sajjadi; A Saboora; P Mohammadi
Journal:  Curr Med Mycol       Date:  2016-06

6.  Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant Candida albicans.

Authors:  Xinning Liu; Tao Li; Decai Wang; Yilei Yang; Wenwen Sun; Jianqiao Liu; Shujuan Sun
Journal:  Front Microbiol       Date:  2017-11-07       Impact factor: 5.640

7.  Antifungal Activity of Thai Cajuput Oil and Its Effect on Efflux-Pump Gene Expression in Fluconazole-Resistant Candida albicans Clinical Isolates.

Authors:  Pitchayaphong Keereedach; Karnjana Hrimpeng; Khaemaporn Boonbumrung
Journal:  Int J Microbiol       Date:  2020-11-04

8.  Overexpression or Deletion of Ergosterol Biosynthesis Genes Alters Doubling Time, Response to Stress Agents, and Drug Susceptibility in Saccharomyces cerevisiae.

Authors:  Somanon Bhattacharya; Brooke D Esquivel; Theodore C White
Journal:  MBio       Date:  2018-07-24       Impact factor: 7.867

9.  Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.

Authors:  Rabiye Altinbaş; Ayşe Barış; Sümeyye Şen; Recep Öztürk; Nuri Kiraz
Journal:  Turk J Med Sci       Date:  2020-12-17       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.